Lysine Reduction and Cognitive Outcomes in Pyridoxine-Dependent Epilepsy: A New Approach to an Old Disease

Neurology. 2022 Dec 5;99(23):1025-1026. doi: 10.1212/WNL.0000000000201270.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aldehyde Dehydrogenase
  • Cognition
  • Epilepsy* / drug therapy
  • Humans
  • Lysine*
  • Pyridoxine / therapeutic use

Substances

  • Lysine
  • Pyridoxine
  • Aldehyde Dehydrogenase

Supplementary concepts

  • Pyridoxine-dependent epilepsy